TransMedics to Report Second Quarter 2025 Financial Results on July 30, 2025

Rhea-AI Summary

TransMedics (NASDAQ: TMDX), a medical technology company focused on organ transplant therapy, has scheduled its Second Quarter 2025 financial results announcement for July 30, 2025, after market close.

The company will host a conference call at 4:30 p.m. ET / 1:30 p.m. PT to discuss the results. Investors can join via phone using specific dial-in numbers or access the webcast through TransMedics' investor relations website.

News Market Reaction

-0.71%

1 alert

-0.71% News Effect

On the day this news was published, TMDX declined 0.71%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

ANDOVER, Mass., July 16, 2025 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure, today announced that it will release financial results for the second quarter 2025 after market close on Wednesday, July 30, 2025. The TransMedics management team will host a corresponding conference call beginning at 4:30 p.m. ET / 1:30 p.m. PT.

Investors interested in listening to the conference call may do so by dialing (844) 676-6010 for domestic callers or (412) 634-6944 for international callers and ask to be joined into the TransMedics call. A live and archived webcast of the event will be available on the "Investors" section of the TransMedics website at https://investors.transmedics.com/.

About TransMedics Group, Inc.
TransMedics is the world's leader in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Headquartered in Andover, Massachusetts, the company was founded to address the unmet need for more and better organs for transplantation and has developed technologies to preserve organ quality, assess organ viability prior to transplant, and potentially increase the utilization of donor organs for the treatment of end-stage heart, lung, and liver failure.

Investor Contact:
Brian Johnston
Laine Morgan
332-895-3222
Investors@transmedics.com 

View original content to download multimedia:https://www.prnewswire.com/news-releases/transmedics-to-report-second-quarter-2025-financial-results-on-july-30-2025-302506922.html

SOURCE TransMedics Group, Inc.

FAQ

When will TransMedics (TMDX) release Q2 2025 earnings?

TransMedics will release its Q2 2025 financial results on Wednesday, July 30, 2025 after market close.

What time is the TransMedics Q2 2025 earnings call?

The earnings conference call will begin at 4:30 p.m. ET / 1:30 p.m. PT on July 30, 2025.

How can investors join the TransMedics Q2 2025 earnings call?

Investors can join by dialing (844) 676-6010 (domestic) or (412) 634-6944 (international) and asking to join the TransMedics call.

Where can I access the webcast of TransMedics Q2 2025 earnings call?

The live and archived webcast will be available on the Investors section of TransMedics' website at investors.transmedics.com.